Profound and Sustained Reductions in Lipoprotein(a) With Olpasiran
Treatment with olpasiran -- a small interfering RNA product targeting lipoprotein(a), or Lp(a),…
Browsing Tag
lipoproteina
Clinical trial finds novel therapy markedly reduced lipoprotein(a) levels in people…
Researchers at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, conducted a phase 2, randomized, placebo-controlled clinical trial of olpasiran…
Experimental ‘gene silencing’ therapy reduces lipoprotein(a), an important risk…
Findings from a new Cleveland Clinic-led phase 1 trial show that an experimental "gene silencing" therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to…